In News:

Recent advancements in artificial intelligence (AI) may significantly accelerate the diagnosis of coeliac disease, an inherited autoimmune disorder triggered by gluten consumption. Researchers at the University of Cambridge have developed an AI-based tool capable of diagnosing the disease swiftly and accurately, potentially transforming current diagnostic practices.

What is Coeliac Disease?

• Nature: An inherited autoimmune disorder.
• Cause: Triggered by consumption of gluten, a protein found in wheat, barley, and rye.
• Mechanism: Gluten intake causes an immune reaction in the small intestine, damaging the intestinal lining (villi), leading to malabsorption of nutrients.

Key Symptoms:

• Gastrointestinal: Diarrhoea, bloating, stomach cramps, weight loss
• Systemic: Fatigue, anaemia, skin rashes
• In children: Impaired growth and development
• Long-term complications: Malnutrition, osteoporosis, infertility, anaemia, and increased risk of autoimmune diseases and certain cancers

Prevalence and Risk Factors:

• Affects approximately 1 in 100 people worldwide
• About 700,000 people in the UK live with the disease
• Individuals with a first-degree relative (parent, sibling, or child) with coeliac disease have a 1 in 10 risk
• It can develop at any age after gluten consumption begins

Diagnosis and Treatment:

• Current Diagnostic Method:
  • Blood tests to detect gluten antibodies
  • Duodenal biopsy to assess damage to villi (requires analysis by pathologists)
• Treatment: No cure; managed through a strict lifelong gluten-free diet

AI-Based Diagnostic Advancement:

• Development: By University of Cambridge researchers
• Function: The AI model analyses biopsy images to detect villous damage
• Training: Based on 4,000+ biopsy images from five hospitals using scanners from four manufacturers
• Efficiency: Matches the accuracy of expert pathologists, with diagnosis in under a minute
• Impact: Could eliminate delays caused by backlog in pathology labs and speed up diagnosis for patients

Significance of AI in Healthcare:

• Benefits:
  • Faster diagnosis for patients
  • Reduces burden on pathologists and NHS waiting lists
  • Frees up time for pathologists to focus on more critical cases (e.g., cancer)
• Expert Support:Recognised by the Royal College of Pathologists as a tool with the potential to transform diagnostic pathology
• Future Requirements:
  • Investment in digital pathology
  • Integrated IT systems across health organisations
  • Training for medical professionals in AI-based diagnostic tools